Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

NAOV

NanoVibronix (NAOV)

NanoVibronix Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NAOV
DateTimeSourceHeadlineSymbolCompany
11/14/20238:30AMBusiness WireNanoVibronix Issues Letter to ShareholdersNASDAQ:NAOVNanoVibronix Inc
11/13/20234:44PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NAOVNanoVibronix Inc
11/07/20238:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NAOVNanoVibronix Inc
11/07/20238:30AMBusiness WireNanoVibronix UroShield Products Available on NHS Drug Tariff Effective November 1NASDAQ:NAOVNanoVibronix Inc
09/27/20238:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NAOVNanoVibronix Inc
09/27/20238:00AMBusiness WireNanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services’ Drug TariffNASDAQ:NAOVNanoVibronix Inc
09/22/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:NAOVNanoVibronix Inc
09/21/202310:27AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:NAOVNanoVibronix Inc
09/21/202310:25AMEdgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:NAOVNanoVibronix Inc
09/13/20234:45PMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:NAOVNanoVibronix Inc
09/12/20234:15PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:NAOVNanoVibronix Inc
09/06/20238:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NAOVNanoVibronix Inc
09/06/20238:30AMBusiness WireNanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual MeetingNASDAQ:NAOVNanoVibronix Inc
09/01/20234:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NAOVNanoVibronix Inc
08/30/20232:29PMBusiness WireNanoVibronix Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq RulesNASDAQ:NAOVNanoVibronix Inc
08/30/20238:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NAOVNanoVibronix Inc
08/30/20238:30AMBusiness WireNanoVibronix Cites Positive Results from Independent Testing of UroShieldNASDAQ:NAOVNanoVibronix Inc
08/29/20234:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NAOVNanoVibronix Inc
08/29/20234:05PMBusiness WireNanoVibronix Responds to CMS’ Determination for PainShieldNASDAQ:NAOVNanoVibronix Inc
08/28/20238:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NAOVNanoVibronix Inc
08/28/20238:30AMBusiness WireNanoVibronix Applies for Inclusion of UroShield Products in NHS Prescription Services’ Drug TariffNASDAQ:NAOVNanoVibronix Inc
08/23/20234:45PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NAOVNanoVibronix Inc
08/23/20238:45AMBusiness WireNanoVibronix Extends Distribution Agreement with Its Largest Distributor for PainShield and PainShield PlusNASDAQ:NAOVNanoVibronix Inc
08/14/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:NAOVNanoVibronix Inc
08/11/20235:20PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NAOVNanoVibronix Inc
08/07/20235:14PMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:NAOVNanoVibronix Inc
08/01/20234:30PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:NAOVNanoVibronix Inc
07/20/20234:45PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NAOVNanoVibronix Inc
07/17/20235:01PMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:NAOVNanoVibronix Inc
06/21/20235:01PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NAOVNanoVibronix Inc
 Showing the most relevant articles for your search:NASDAQ:NAOV